HEALTHCARE RESOURCE USE AND COSTS IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS IN THE US MEDICARE POPULATION

被引：0
|
作者：
Reddy, Sheila
Chang, Eunice
Broder, Michael
Gokhale, Sohum
Corral, Mitra
机构：
来源：
CHEST | 2019年 / 156卷 / 04期
关键词：
D O I：
10.1016/j.chest.2019.08.470
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：440A / 441A
页数：2
相关论文
共 50 条
  • [1] HEALTHCARE RESOURCE USE AND COST IN ANTIFIBROTIC-TREATED VS UNTREATED PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF) IN THE US MEDICARE POPULATION
    Corral, Mitra
    Chang, Eunice
    Broder, Michael
    Gokhale, Sohum
    Reddy, Sheila
    [J]. CHEST, 2020, 158 (04) : 1057A - 1057A
  • [2] Healthcare resource use and related costs in patients receiving nintedanib or pirfenidone for idiopathic pulmonary fibrosis
    Bonniaud, Philippe
    Cottin, Vincent
    Spagnolo, Paolo
    Nolin, Maeva
    Dalon, Faustine
    Kirchgassler, Klaus-Uwe
    Chia, Jenny
    Kamath, Tripthi
    Van Ganse, Eric
    Belhassen, Manon
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [3] Healthcare resource use and associated costs in patients receiving pirfenidone or nintedanib for idiopathic pulmonary fibrosis
    Cottin, Vincent
    Spagnolo, Paolo
    Bonniaud, Philippe
    Dalond, Faustine
    Nolind, Maeva
    Kirchgassler, Klaus-Uwe
    Van Ganse, Eric
    Belhassen, Manon
    [J]. RESPIRATORY MEDICINE AND RESEARCH, 2023, 83
  • [4] Healthcare use and costs among Medicare enrollees on pirfenidone versus nintedanib for idiopathic pulmonary fibrosis
    Corral, Mitra
    Chang, Eunice
    Broder, Michael S.
    Gokhale, Sohum
    Reddy, Sheila R.
    [J]. JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2020, 9 (13) : 933 - 943
  • [5] End Of Life Costs For Medicare Patients With Idiopathic Pulmonary Fibrosis
    Mooney, J.
    Raimundo, K.
    Chang, E.
    Reddy, S. R.
    Papoyan, E.
    Broder, M. S.
    Stauffer, J. L.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [6] AN ANALYSIS OF US MEDICARE BENEFICIARIES: BURDEN OF DIRECT MEDICAL COSTS IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
    Chen, S. Y.
    Collard, H. R.
    Yeh, W. S.
    Li, Q.
    Lee, Y. C.
    Wang, A.
    Raghu, G.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A592 - A592
  • [7] Influence of Idiopathic Pulmonary Fibrosis Progression on Healthcare Resource Use
    Alex Diamantopoulos
    Toby M. Maher
    Nils Schoof
    Dirk Esser
    Corinne LeReun
    [J]. PharmacoEconomics - Open, 2019, 3 : 81 - 91
  • [8] Influence of Idiopathic Pulmonary Fibrosis Progression on Healthcare Resource Use
    Diamantopoulos, Alex
    Maher, Toby M.
    Schoof, Nils
    Esser, Dirk
    LeReun, Corinne
    [J]. PHARMACOECONOMICS-OPEN, 2019, 3 (01) : 81 - 91
  • [9] HEALTHCARE RESOURCE USE (HCRU) AND COSTS ASSOCIATED WITH IDIOPATHIC PULMONARY FIBROSIS (IPF): A TARGETED LITERATURE REVIEW
    Coteur, G.
    Bastian, A.
    Clarke, D.
    Langley, J.
    [J]. VALUE IN HEALTH, 2020, 23 : S720 - S720
  • [10] IMPACT OF ANTIFIBROTIC USE ON HEALTHCARE RESOURCE USE AND COST IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF) IN A COMMERCIALLY INSURED PATIENT POPULATION
    Corral, Mitra
    Deyoung, Kathryn
    Kong, Amanda
    [J]. CHEST, 2019, 156 (04) : 1137A - 1137A
12345